Bioventus Inc. (BVS) vs SI-BONE, Inc. (SIBN)

A side-by-side comparison of Bioventus Inc. and SI-BONE, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BVS vs SIBN

growth of $100 · dividends reinvested · last 6y
BVS -29.6% (-5.7%/yr)SIBN -37.7% (-7.6%/yr)BVS compounded faster over this window
020406080100Start $10020222023202420252026$70$62
BVS SIBN

BVS vs SIBN: by the numbers

  • •BVS is the larger company ($887M vs $867M market cap).
  • •BVS is profitable (9.36% net margin) while SIBN runs a net loss (-6.85%).
  • •SIBN grew revenue faster over the past five years (20.20% vs 11.82% CAGR).

Metrics side by side

Valuation

MetricBVSSIBN
P/E ratio17.01N/A
Forward P/E16.82N/A
P/S ratio1.534.06
P/B ratio3.894.75
EV / EBITDA10.48N/A
FCF yield10.62%N/A

Profitability

MetricBVSSIBN
Gross margin68.00%79.53%
Operating margin10.63%-8.31%
Net margin9.36%-6.85%
ROE23.86%-8.03%
ROIC11.37%-7.88%

Growth (annualized)

MetricBVSSIBN
Revenue CAGR (5Y)11.82%20.20%
EPS CAGR (5Y)-5.03%N/A
FCF CAGR (5Y)43.36%N/A
Total return CAGR (5Y)-0.81%-1.46%

Frequently asked

Which has grown faster, BVS or SIBN?
Over the past five years, SIBN grew revenue faster — BVS at a 11.82% CAGR versus SIBN at 20.20%.
Is BVS or SIBN more profitable?
BVS runs the higher net margin — BVS at 9.36% versus SIBN at -6.85%.
How have BVS and SIBN total returns compared?
Over the past 5 years, BVS delivered -0.81% and SIBN delivered -1.46% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.